Food and Drug Administration Medwatch

Department ol Health and Human Services Food and Drug Administration - MedWatch 10903 New Hampshire Avenue Building 22. Mail Stop 4447 Silver Spring, MD 20993-0002 Please DO NOT RETURN this form to this address. 

U.S. Food and Drug Administration. Medwatch. www.jda.gov/medwaich/safety.htm Veenstra, D.L., et al., "Assessing the Cost-Effectiveness of Pharmacogenomics," AAPS PharmSci., 2 (3), 1-11 (2000) article 29 (http /www.pharmsci.org)... 

U.S. Food and Drug Administration. MedWatch 2004 Safety Information Alerts. Vioxx Sep 2004. http // www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucml66532.htm (accessed July 2012). 

Food and Drug Administration - MedWatch RETURN this form... 

Food and Drug Administration MEDWATCH, FDA Medical Products Reporting Program 5600 Fishers Lane Rockville. MD 20857-9787 (800)332-1088... 

Gruchalla, R.S. (1995). A one-year perspective on MedWatch The Food and Drug Administration s new medical products reporting program. J. Allergy Clinical Immunology 95 1153-1157. 

Sources (1) Food and Drug Administration, Fuzeon. http //www.fda.gov/medwatch/ SAFETY/2004/oct PI/Fuzeon PI.pdf [accessed September 28, 2007]. (2) Food and Drug Administration, Selzentry. http //www.fda,gov/cder/drug/mg/maravirocMG.pdf [accessed September 28,2007]. 

Source Food and Drug Administration. Avastin. http //www.fda.gov/medwatch/ SAFETY/2005/Jan PI/Avastin PI.pdf [accessed September 17,2007]. 

Wysowski DK, Green L. Serious adverse events in Norplant users reported to the Food and Drug Administration s MedWatch Spontaneous Reporting System. Obstet Gynecol 1995 85(4) 538-42. 

Kennedy, D. L., McGinnis, T. (1993, September). Monitoring adverse drug reactions The FDA s new MedWatch program. Rockville, MD Food and Drug Administration. 

Figure 35-16 U.S. Food and Drug Administration s MEDWatch adverse drug reaction volimtary reporting form (accessed April 2007).

Food and Drug Administration. Safety alerts for human medical products—Xeo-loda (capecitabine) 2009. http //www.fda. gov/Safety/MedWatch/SafetyInformation/ Safety AlertsforHumanMedicalProducts/ ucml72670.htm. 

---